Literature DB >> 10615270

Transport and temperature effects on measurement of serum and plasma potassium.

D Seamark1, S Backhouse, P Barber, J Hichens, M Salzmann, R Powell.   

Abstract

Transport of blood samples from general practice to a central laboratory can result in spuriously high or low potassium concentrations. The importance of this phenomenon was studied in a general practice serving a population of 15,000 patients, 27 km from the pathology laboratory that routinely measured serum potassium. The design involved comparison of potassium levels between control serum (plain gel-separation serum tubes centrifuged in the surgery), routine serum (plain gel-separation tubes centrifuged in the laboratory) and routine plasma samples (lithium-heparin tubes centrifuged in the laboratory). Complete triple sets of data were obtained for 371 samples. Altman and Bland plots for the control serum vs routine serum samples showed a mean difference of +0.1 mmol/L with limits of agreement (+/- 2SD) +0.6 mmol/L, -0.4 mmol/L and for control serum vs routine plasma a mean difference of +0.2 mmol/L with limits of agreement +0.8 mmol/L, -0.4 mmol/L. There was a negative association between mean weekly routine plasma potassium levels with mean weekly temperatures achieved. Regression analysis indicated that both maximum temperature achieved and time to centrifugation significantly contributed to differences observed in the routine plasma samples, but not with the routine serum samples. For plasma samples exposed to high temperatures a clinically significant lowering of potassium concentrations can arise. These results confirm that spurious lowering of potassium concentrations occurs in plasma samples collected in a primary care setting. The preferred method is to centrifuge samples soon after venepuncture. Where this is not possible, collection into plain gel-separation tubes (serum) ensures less variation due to temperature and time to centrifugation than does collection into lithium-heparin tubes (plasma).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615270      PMCID: PMC1297284          DOI: 10.1177/014107689909200703

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  7 in total

1.  Evaluation of serum potassium levels.

Authors:  J H WEBSTER; J NEFF; S S SCHIAFFINO; A M RICHMOND
Journal:  Am J Clin Pathol       Date:  1952-09       Impact factor: 2.493

2.  Commentary: replication of results.

Authors:  M D Buckley-Sharp; D A Gardner
Journal:  BMJ       Date:  1996-06-29

3.  High ambient temperature: a spurious cause of hypokalaemia.

Authors:  P W Masters; N Lawson; C B Marenah; L J Maile
Journal:  BMJ       Date:  1996-06-29

4.  Analysis of method comparison studies.

Authors:  S Hollis
Journal:  Ann Clin Biochem       Date:  1996-01       Impact factor: 2.057

5.  The alteration of serum potassium level during sample transit.

Authors:  D Moore; P Walker; A Ismail
Journal:  Practitioner       Date:  1989-03-22

6.  Effects of needle size and storage temperature on measurements of serum potassium.

Authors:  L Verresen; R L Lins; H Neels; M E De Broe
Journal:  Clin Chem       Date:  1986-04       Impact factor: 8.327

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

  7 in total
  4 in total

Review 1.  Best practice in primary care pathology: review 9.

Authors:  W S A Smellie; N Shaw; R Bowlees; A Taylor; R Howell-Jones; C A M McNulty
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

Review 2.  Spurious hyperkalaemia.

Authors:  W Stuart A Smellie
Journal:  BMJ       Date:  2007-03-31

3.  Seasonal pseudohyperkalaemia.

Authors:  D Sinclair; P Briston; R Young; N Pepin
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

4.  Stability of 35 biochemical and immunological routine tests after 10 hours storage and transport of human whole blood at 21°C.

Authors:  Linda O Henriksen; Nina R Faber; Mette F Moller; Ebba Nexo; Annebirthe B Hansen
Journal:  Scand J Clin Lab Invest       Date:  2014-07-02       Impact factor: 1.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.